by EpicentRx | Feb 2, 2024 | Blog
True we don’t carry an FBI badge like the facsimile of the one pictured above, but feel free to call us G-men (and women) anyway. That’s because as drug developers we must, by law, strictly adhere to the “G-regulations” as in GLP, GCP, GMP, and GDP. The “G” in this...
by EpicentRx | Jan 29, 2024 | Blog
“To be gnathonic is also to be somewhat ironic.” Gnathonic adjective na-thon-ik gnathonically adverb na-thon-ik-uh-lee Definition: fawning or flattering Example sentence: “’Both your parties’ candidates are...
by EpicentRx | Jan 26, 2024 | Blog
If the hybrid and “diverse” small molecule, RRx-001 (nibrozetone) could spit in a vial and ship it off to 23andMe, a DNA mapping service that extracts genealogical data from saliva, the breakdown would read as follows: 50% Western United States where it was...
by EpicentRx | Jan 26, 2024 | Blog
If the “smart” oncolytic adenovirus, AdAPT-001, assuming it really was that smart, could spit in a vial and ship it off to 23andMe, a DNA mapping service that extracts genealogical data from saliva, the breakdown would read as follows: 80% Western United States where...
by EpicentRx | Jan 24, 2024 | Blog
To leapfrog is to improve position by means of vaulting. In drug development it is vaunted to be vaulted into special position via FDA expedited approval programs. The 5 programs whose labels confer special status on the companies that receive them are: Priority...
